This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (33)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Howard V. Dubin, MD; E. Richard Harrell, MD

Arch Dermatol. 1970;102(5):498-503.

Abstract
Three patients developed hepatic toxicity associated with antifolate treatment of psoriasis. Two of the three patients had abnormal liver biopsies in spite of reversion to normal of liver function test results. The problem of methotrexate toxicity in psoriatic patients is discussed with special reference to hepatic toxicity. Hepatic histologic abnormalities may be present after methotrexate has been discontinued and results of liver function tests have reverted to normal. Patients who have discontinued methotrexate because of abnormal liver function tests should undergo a liver biopsy before the drug is restarted even if results of liver function tests have reverted to normal. It is not known if severe histologic abnormalities might be present when liver function test results remain normal during the course of treatment. This ultimately will be determined from prospective studies.

Author Affiliations
Ann Arbor, Mich

From the Department of Dermatology, University of Michigan Medical Center, Ann Arbor, Mich.

Footnotes
Accepted for publication July 1, 1970.

Reprint requests to Department of Dermatology, University of Michigan Medical Center, Ann Arbor, Mich 48104 (Dr. Dubin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multinucleated Hepatocytes Induced by Rifabutin in Rats
Scampini et al.
Toxicol Pathol 1993;21:369-376.
ABSTRACT  

Methotrexate and Hepatic Disease
Tashima
JAMA 1971;216:2018-2018.
ABSTRACT